AI Science Tracker
EN

The Second Qilu Hospital of Shandong University

1 discovery from 2026

Discoveries

Risk Assessment for Upper Urinary Tract Deterioration in Patients With Neurogenic Bladder: A Retrospective Study Using Interpretable Machine Learning Algorithms.

Source check: Source checked. Not independent scientific confirmation.

Finding: A retrospective patient cohort evaluates machine-learning risk prediction for neurogenic-bladder deterioration. The publisher Methods and Results were checked; this conclusion is limited to the study cohort, reference standard and validation described there.

Technology: A retrospective patient cohort evaluates machine-learning risk prediction for neurogenic-bladder deterioration.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
A retrospective patient cohort evaluates machine-learning risk prediction for neurogenic-bladder deterioration.
Test and result
Validation design, cohort/reference and reported metrics were checked in the source; no broader clinical claim is made.
Limitation / still unknown
The reviewed source does not establish prospective benefit, broad external validity, or replication beyond the reported study.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13643472/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.